BRADLEY BIGFORD: Open Payments
NPI 1588007843 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $72 |
| Novo Nordisk Inc | 1 | $29 |
| Exact Sciences Corporation | 1 | $29 |
| Lundbeck LLC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $18 |
| Innovation Technologies Inc | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $10 |
Products named: Veozah, Wegovy, Cologuard Collection Kit, REXULTI, SLYND, IRRISEPT, Symbravo.
Industry payments across ID — which companies pay providers there.
